Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
G1 Therapeutics
AddedFeb 19, 2024
UpdatedJun 18, 2026
G1 Therapeutics

G1 Therapeutics

Public

US-based G1 Therapeutics develops innovative treatments for oncology and breast cancer.

HQ
Triangle (historical), NC, US
Founded
2008
Overview
Compare
Fundraising
Employees
Website

Founded in Durham, United States, G1 Therapeutics is a pharmaceutical company dedicated to developing next-generation cancer therapies. Their core mission is to improve the lives and outcomes of people living with cancer, with a particular focus on oncology and breast cancer treatments. G1 Therapeutics offers innovative therapeutic solutions aimed at addressing unmet medical needs in the healthcare sector within the United States.

Notable affiliated individuals include key researchers and industry experts who have contributed to the company's advancements. G1 Therapeutics has attracted significant investment from leading healthcare investors, bolstering its research and development efforts. Key achievements include the development of novel therapeutics that have shown promise in clinical trials, positioning the company as a significant player in the oncology treatment landscape. The overall impact of G1 Therapeutics is reflected in its commitment to enhancing cancer care and improving patient outcomes.

G1 Therapeutics - Similar Companies

Traws Pharma logo

Traws Pharma

Revolution Medicines logo

Revolution Medicines

revmed.com

Advanced Cancer Therapeutics logo

Advanced Cancer Therapeutics

Clovis Oncology logo

Clovis Oncology

OnCusp Therapeutics logo

OnCusp Therapeutics

oncusptx.com

BeOne Medicines logo

BeOne Medicines

beigene.com

Palm Therapeutics logo

Palm Therapeutics

Checkpoint Therapeutics logo

Checkpoint Therapeutics

checkpointtx.com

Tango Therapeutics logo

Tango Therapeutics

tangotx.com

MacroGenics logo

MacroGenics

macrogenics.com

Kronos Bio logo

Kronos Bio

Cullinan Oncology logo

Cullinan Oncology

Gliknik logo

Gliknik

gliknik.com

TG Therapeutics logo

TG Therapeutics

tgtherapeutics.com

Blueprint Medicines logo

Blueprint Medicines

G1 Therapeutics - Quick Facts

Who are G1 Therapeutics' competitors?

Companies similar to G1 Therapeutics include Traws Pharma, Revolution Medicines, Advanced Cancer Therapeutics and Clovis Oncology.

When was G1 Therapeutics founded?

G1 Therapeutics was founded in 2008.

Where is G1 Therapeutics' headquarters located?

G1 Therapeutics' headquarters is located in Triangle (historical), NC, US.

When was G1 Therapeutics' last funding round?

G1 Therapeutics' most recent funding round was for $50M (USD) in November 2022.

How much has G1 Therapeutics raised to-date?

As of Nov 17, 2022, G1 Therapeutics has raised a total of $697.4M (USD).

How many employees does G1 Therapeutics have?

G1 Therapeutics has 170 employees as of Feb 6, 2024.

G1 Therapeutics - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Cancer Therapies
Tags
  • Healthcare
  • Healthtech
  • Pharmaceutical
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 14 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research